Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Rating) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 33,100 shares, an increase of 13.4% from the March 31st total of 29,200 shares. Based on an average daily trading volume, of 26,200 shares, the days-to-cover ratio is currently 1.3 days.

Algernon Pharmaceuticals Price Performance

Shares of Algernon Pharmaceuticals stock opened at $0.19 on Friday. Algernon Pharmaceuticals has a one year low of $0.17 and a one year high of $1.33. The business has a 50-day simple moving average of $0.30 and a 200-day simple moving average of $0.41.

About Algernon Pharmaceuticals

(Get Rating)

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand.

See Also

• Get a free copy of the StockNews.com research report on Algernon Pharmaceuticals (AGNPF)
• MarketBeat Week in Review – 4/24 – 4/28
• How to Invest in the Top Grocery Stocks for This Year
• Array Technologies Brings Solar Flare To 2023 Earnings Forecast
• Best Bank Stocks to Invest in Ahead of Rising Interest Rates
• How to Invest in Farmland: 7 Simple Ways

Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.